Search

everythinglearnresearchcommunity

for

Search:↓

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

The Shumin device with doxycycline is more effective for rosacea than red light therapy.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Wedelolactone may help reduce bone loss with fewer side effects.

UVFD can help doctors better identify harmful skin lesions on the face, reducing unnecessary biopsies.

A new method accurately measures DHEAS in blood, improving on current tests.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Ectodysplasin inhibits Wnt signaling to help form hair follicles.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Dab2 protein is crucial for hair follicle stem cell renewal and preventing early aging.

Finasteride effectively treats BPH by reducing prostate size and improving symptoms.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Decorin helps hair cells grow and move, and keeps hair growth phase going in mice.